WO2003059356A3 - Novel anti-infectives - Google Patents

Novel anti-infectives Download PDF

Info

Publication number
WO2003059356A3
WO2003059356A3 PCT/US2002/034591 US0234591W WO03059356A3 WO 2003059356 A3 WO2003059356 A3 WO 2003059356A3 US 0234591 W US0234591 W US 0234591W WO 03059356 A3 WO03059356 A3 WO 03059356A3
Authority
WO
WIPO (PCT)
Prior art keywords
infectives
novel anti
disclosed
making
methods
Prior art date
Application number
PCT/US2002/034591
Other languages
French (fr)
Other versions
WO2003059356A2 (en
Inventor
Michael G Darcy
Dashyant Dhanak
Kevin J Duffy
Duke M Fitch
Robert T Sarisky
Antony N Shaw
Rosanna Tedesco
Michael N Zimmerman
Original Assignee
Smithkline Beecham Corp
Michael G Darcy
Dashyant Dhanak
Kevin J Duffy
Duke M Fitch
Robert T Sarisky
Antony N Shaw
Rosanna Tedesco
Michael N Zimmerman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Michael G Darcy, Dashyant Dhanak, Kevin J Duffy, Duke M Fitch, Robert T Sarisky, Antony N Shaw, Rosanna Tedesco, Michael N Zimmerman filed Critical Smithkline Beecham Corp
Priority to AU2002365198A priority Critical patent/AU2002365198A1/en
Publication of WO2003059356A2 publication Critical patent/WO2003059356A2/en
Publication of WO2003059356A3 publication Critical patent/WO2003059356A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Disclosed are compounds useful as HCV anti-infectives and methods of making and using the same.
PCT/US2002/034591 2001-10-30 2002-10-28 Novel anti-infectives WO2003059356A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002365198A AU2002365198A1 (en) 2001-10-30 2002-10-28 Novel anti-infectives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33854201P 2001-10-30 2001-10-30
US60/338,542 2001-10-30

Publications (2)

Publication Number Publication Date
WO2003059356A2 WO2003059356A2 (en) 2003-07-24
WO2003059356A3 true WO2003059356A3 (en) 2004-01-22

Family

ID=23325196

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/034591 WO2003059356A2 (en) 2001-10-30 2002-10-28 Novel anti-infectives

Country Status (2)

Country Link
AU (1) AU2002365198A1 (en)
WO (1) WO2003059356A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4738172B2 (en) * 2002-11-01 2011-08-03 アボット・ラボラトリーズ Antiinfectives
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
EP2361913A1 (en) * 2002-11-01 2011-08-31 Abbott Laboratories Anti-infective agents
CN103304541A (en) 2004-02-20 2013-09-18 贝林格尔.英格海姆国际有限公司 Viral polymerase inhibitors
SG137868A1 (en) * 2004-08-23 2007-12-28 Hoffmann La Roche Heterocyclic antiviral compounds
AP2007004040A0 (en) 2004-12-17 2007-06-30 Anadys Pharmaceuticals Inc Pyridazinone compounds
ATE409179T1 (en) 2004-12-21 2008-10-15 Hoffmann La Roche TETRALIN AND INDANDE DERIVATIVES AND THEIR APPLICATIONS AS 5-HT ANTAGONISTS
BRPI0611388A2 (en) 2005-05-04 2010-09-08 Hoffmann La Roche heterocyclic antiviral compounds, their use and pharmaceutical composition
AU2007263084A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Tetralin and indane derivatives and uses thereof
EP2041079A1 (en) 2006-06-20 2009-04-01 F. Hoffmann-Roche AG Arylsulfonyl naphthalene derivatives and uses thereof
WO2007147762A1 (en) 2006-06-20 2007-12-27 F. Hoffmann-La Roche Ag Arylsulfonamidyl tetralin derivatives and uses thereof
WO2007150001A1 (en) * 2006-06-22 2007-12-27 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
WO2008011337A1 (en) 2006-07-19 2008-01-24 Abbott Laboratories Hcv inhibitors
KR20090078347A (en) 2006-10-10 2009-07-17 메디비르 아베 Hcv nucleoside inhibitor
WO2008073987A1 (en) * 2006-12-12 2008-06-19 Anadys Pharmaceuticals, Inc. Saturated fused [1,2-b] pyridazinone compounds
TW200840572A (en) 2006-12-12 2008-10-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
UA100120C2 (en) 2007-04-03 2012-11-26 Анадис Фармасьютикалз, Инк. 5,6-dihydro-1h-pyridin-2-one compounds
US7834009B2 (en) 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
GB0800855D0 (en) * 2008-01-17 2008-02-27 Syngenta Ltd Herbicidal compounds
WO2009152166A1 (en) 2008-06-10 2009-12-17 Anadys Pharmaceuticals, Inc. [1,2,4]thiadiazine 1,1-dioxide compounds
TW201026675A (en) 2008-10-09 2010-07-16 Anadys Pharmaceuticals Inc 5,6-dihydro-1H-pyridin-2-one compounds
ES2435799T3 (en) 2008-10-09 2013-12-23 Anadys Pharmaceuticals, Inc. A method of inhibiting hepatitis C virus by combining a 5,6-dihydro-1H-pyridin-2-one and one or more additional antiviral compounds
CN102203091B (en) * 2008-10-29 2014-08-13 巴斯夫欧洲公司 Substituted pyridines having a herbicidal effect
WO2010100178A1 (en) 2009-03-06 2010-09-10 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
AU2010240888A1 (en) 2009-04-25 2011-11-17 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
JP2012527420A (en) * 2009-05-20 2012-11-08 エフ.ホフマン−ラ ロシュ アーゲー Antiviral heterocyclic compounds
SG176976A1 (en) 2009-06-24 2012-02-28 Hoffmann La Roche Heterocyclic antiviral compound
WO2011033045A1 (en) 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
EP2493476A4 (en) 2009-10-28 2013-06-19 Anadys Pharmaceuticals Inc Deuterated 5,6-dihydro-1h-pyridin-2-one compounds
BR112012012085A2 (en) 2009-11-21 2016-05-17 Hoffmann La Roche heterocyclic antiviral compounds
US20120321590A1 (en) 2011-04-06 2012-12-20 Anadys Pharmaceuticals, Inc. Bridged polycyclic compounds
WO2021030278A1 (en) * 2019-08-12 2021-02-18 Aligos Therapeutics, Inc. Bicyclic compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMISTRY OF HETEROCYCLIC COMPOUNDS (NEW YORK), vol. 36, no. 3, 2000, pages 346 - 350 *
DATABASE CAPLUS [online] UKRAINETS ET AL.: "4-Hydroxy-2-quinolones. Part 42. Synthesis and biological activity of 1-substituted 2-oxo-3-(2H-1,2,4-benzothiadiazine-1,1-dioxid-3-yl)-4-Hydroxyquinolines", XP002956156, accession no. STN Database accession no. 2000:335217 *

Also Published As

Publication number Publication date
AU2002365198A1 (en) 2003-07-30
WO2003059356A2 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
WO2003059356A3 (en) Novel anti-infectives
MXPA03011329A (en) Novel anti-infectives.
WO2003035617A3 (en) Derivatives of uk-2a
MXPA03005960A (en) Novel mixtures of microbial enzymes.
AU2002364528A1 (en) Bio-implant and method of making the same
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
WO2003045840A3 (en) Mesoporous materials and methods
WO2003037262A3 (en) Novel anit-infectives
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
WO2004052313A3 (en) Anti-infectives
WO2004058150A3 (en) Anti-infectives
WO2004052312A3 (en) Anti-infectives
AU2002237265A1 (en) Ring-shaped seal
AU2002347778A1 (en) Enzymes
WO2002034204A8 (en) Calcilytic compounds
WO2004047751A3 (en) Calcilytic compounds
WO2002098924A3 (en) Compositions including fluorinated peroxides, methods of making, and the use thereof
AU2002337150A1 (en) Microchamber
AUPR573601A0 (en) Novel process
AU2002257273A1 (en) Enzymes
AU2002308926A1 (en) The method of preparing of n-n-alkyl benzoyl-2-sulfonylendoimine
AU2002348941A1 (en) Calpain activators
AUPR482001A0 (en) Metal-handling enzymes
AU2002315767A1 (en) Novel aliphatic compounds, synthesis method and method of using the same
ZA200304986B (en) Novel mixtures of microbial enzymes.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP